#Pride month tomorrow starts! HIVgov celebrates the diversity of the LGBTQI+ community and recognizes the stigmas and discrimination the community can face, these influences access to care and builds barriers to living healthy lives. This June, and all year round, be proud of who you are.
Office of Infectious Disease and HIV/AIDS Policy
Government Administration
Washington, D.C. 5.323 followers
Working toward a world free of infectious disease.
About us
The Office of Infectious Disease and HIV/AIDS Policy (OIDP) is located in the Office of the Assistant Secretary for Health (ASH), Office of the Secretary (OS), U.S. Department of Health and Human Services (HHS). Our mission is to provide strategic leadership and management, while encouraging collaboration, coordination, and innovation among federal agencies and stakeholders to reduce the burden of infectious diseases. OIDP works with federal and non-federal stakeholders to develop, coordinate, and implement national strategies and initiatives to prevent infectious diseases. Some of the topics addressed by our working groups and national strategies include: -Antibiotic resistance -Blood and tissue safety and availability -HIV and AIDS -Sexually transmitted infections -Tick-borne diseases -Vaccines and immunization -Viral hepatitis
- Website
-
https://www.hhs.gov/oidp/index.html
External link for Office of Infectious Disease and HIV/AIDS Policy
- Industry
- Government Administration
- Company size
- 5,001-10,000 employees
- Headquarters
- Washington, D.C.
Updates
-
As part of the Ending the HIV Epidemic in the U.S. (EHE) initiative, the 57 prioritized jurisdictions are undertaking a variety of innovative approaches under the initiative’s Prevent pillar, focusing on preventing new HIV transmissions. Read the full blog to learn more about approaches to HIV prevention to reach and engage justice-involved youth, college-aged youth, and healthcare providers:
-
In our first update from SYNC2024, HIV.gov Director Miguel Gomez talks with his colleagues from OIDP, Jessica Deerin and Darcy Cherlin, about their presentations on viral hepatitis.
SYNC2024 Viral Hepatitis Policy and Syndemic Approaches
www.linkedin.com
-
As #HepatitisAwarenessMonth End of
Translation comes to a close, we extend our appreciation to all those working to improve understanding of viral hepatitis transmission and risk factors and to decrease social stigma against viral hepatitis. The CDC offers materials that you can adapt to continue your messaging throughout the year, including: ◾The ABCs of Viral Hepatitis: to help others learn facts about the three most common types of viral hepatitis in the United States. ◾Materials about hepatitis B for Asian and African immigrant audiences. ◾Materials about hepatitis C for health care providers from Know More Hepatitis. ◾Resources about hepatitis A, hepatitis B, and hepatitis C for clinicians and the public. Find them here: https://lnkd.in/dvHQzgZ #HepAware24 -
The Ending the HIV Epidemic in the U.S (#EHE) initiative is a collaborative effort to engage stakeholders and partners at the local, state, and federal levels to address the #HIVepidemic. Leveraging scientific advancements, the initiative focuses on four key strategies to end the HIV epidemic: ◼️Diagnose ◼️Treat ◼️Prevent ◼️Respond The EHE initiative is a core part of HHS’s work to implement the National HIV/AIDS Strategy. Learn more about EHE: https://brnw.ch/21wKh79
-
Francisco Ruiz, the White House Office of National AIDS Policy director, and Brian Hujdich, executive director at HealthHIV and National Coalition for LGBT Health, join Miguel Gomez to discuss highlights from the SYNC2024 conference and the federal plenary.
SYNC2024 Federal Plenary and Conference Highlights
www.linkedin.com
-
HIV Long-Term Survivors Awareness (LTSAD) Day is 1 week away. To learn more about LTSAD visit https://brnw.ch/21wKfTY
-
Tomorrow, HIVgov’s Miguel Gomez will be sharing live updates on our social media channels from #SYNC2024 in Arlington, VA. Join the first livestream around 11:30 AM EST for a discussion with OIDP colleagues about their presentations on viral hepatitis policy and syndemic approaches. Join the second livestream around 2:20 PM EST for a federal plenary recap and conference highlights with The White House Office of National AIDS Policy Director Francisco Ruiz and HealthHIV and National Coalition for LGBTQ Health Executive Director Brian Hujdich.
-
Did you know OIDP leverages expert advice to prevent infectious diseases through four federal advisory committees and workgroups? They include: ◾ Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA): Providing vital policy guidance on blood, blood products, and tissues. ◾ Presidential Advisory Council on HIV/AIDS (PACHA): Offering insights and recommendations to the Secretary on HIV/AIDS programs, policies, and research. ◾ Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB): Advising on strategies to combat antibiotic-resistant bacteria and evaluate related government activities. ◾ National Vaccine Advisory Committee (NVAC): Recommending ways to optimize disease prevention through vaccine development and ensuring vaccine safety. These federal advisory committees play an important role in making rules and plans to keep people healthy. Let's keep working together to make sure everyone stays well in the future! To learn more about OIDP’s advisory committees, visit: https://lnkd.in/gKruSfQJ
-
📌📅 Save the date: The next meeting of the National Vaccine Advisory Committee (#NVAC) will take place June 13-14. Mark your calendars and stay tuned for agenda details! __ NVAC recommends ways to achieve optimal prevention of human infectious diseases through vaccine development and provides direction to prevent adverse reactions to vaccines. This advice is presented to the Assistant Secretary for Health, who serves as the Director of the National Vaccine Program, on matters related to program responsibilities.